ClinicalTrials.gg
RecruitingNCT07805668Updated Sep 4, 2026

Emotional Dysregulation and Other Psychopathological Dimensions in Clinical Preschoolers

An observational study in Behavioral and Emotional Disorder With Onset in Childhood, sponsored by IRCCS Fondazione Stella Maris. Recruiting at 1 site in Italy. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by IRCCS Fondazione Stella Maris · Observational

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.
Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
40
Ages
3 Years to 6 Years
Sex
All
01

Study summary

The purpose of the study is to investigate the emotional-behavioral dysregulation and its possible correlation with the main demographic and psychopathological variables in a sample of preschool children with internalizing and externalizing disorders.

Read the detailed description

This observational study aims to collect data (both prospective and retrospective from 2025) regarding a sample of children aged between 3 and 6 years who were referred in a naturalistic setting to the Department of Developmental Psychiatry and Psychopharmacology at the IRCCS Stella Maris Foundation and to the Child Neuropsychiatry Unit of the IRCCS Giannina Gaslini (multicenter study) for diagnostic assessment, and who received a diagnosis of an internalizing and/or externalizing disorder following the clinical assessment. Through a back-translation procedure, our research group translated and adapted into Italian the "Emotion Dysregulation Inventory Young Child (EDI-YC)" questionnaire for the assessment of emotional-behavioral dysregulation in preschool children. Children will be enrolled according to the eligibility criteria and after informed consent for participation in the study has been signed by both parents/legal guardians. For the collection of retrospective data only, as provided for by the study, and where explicit consent from the parents/legal guardians could not be obtained, the data will be collected in accordance with Article 110-bis, paragraph 4, of the Italian Privacy Code. The data about emotional-behavioral dysregulation obtained from the completion of the EDI-YC will be correlated with data obtained from other questionnaires and from the clinical assessment in order to achieve a characterization of clinical phenotypes based on the psychopathological dimensions investigated.

Executive functions will be investigated in the sample of preschool children through a correlation analysis between BRIEF-P scores and EEG recordings

02

Conditions studied

  • Behavioral and Emotional Disorder With Onset in Childhood

Browse trials for

03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's planned enrollment of 40 is below the median of 235 across 341 observational studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

IRCCS Fondazione Stella Maris is the lead sponsor of 46 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

For the study, patients aged between 3 and 6 years who were referred in a naturalistic setting for diagnostic assessment, and who received a diagnosis of an emotional-behavioral disorder following the routine clinical assessment, will be enrolled.

Eligibility criteria

Inclusion Criteria:

Inclusion criteria:

  • Age between 3 and 6 years
  • Presence of an internalizing and/or externalizing disorder
  • Parent completion of the questionnaires
  • Parent/caregiver signed for participation in the study

Exclusion criteria:

  • Age greater than 6 years
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
40 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. EDI-YC (Emotional Dysregulation Inventory-Young Child)

    EDI-YC is a questionnaire developed to assess emotional dysregulation (ED) in children aged 2 to 5 years, both with and without neuropsychological disabilities. Parents are asked to rate their children's emotional behaviors by assigning a score reflecting the frequency and intensity of emotional dysregulation manifestations (0 = not at all; 4 = very serious).

    Time frame: Baseline

Secondary outcomes

  1. BRIEF-P (Behavior Rating Inventory of Executive Function-Preschool Version)

    BRIEF-P is a parent questionnaire that assesses various aspects of Executive Functions in preschool-aged children, including Inhibition, Emotional Control, Shifting/Flexibility, Planning and Organization, and Working Memory. Parents evaluate, using a 3-point rating scale (1 = never; 3 = always), the frequency with which the behaviors described in each item occur.

    Time frame: Baseline

  2. Sleep-wake EEG recording

    Sleep-wake EEG is an electroencephalographic recording that evaluates brain electrical activity during wakefulness and sleep.

    Time frame: Up to 24 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Oct 2026, 11 months after the start.

Of 113 non-industry observational studies under Behavior, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 57. This study's planned 11 months is below that.

Counting every sponsor, half of 119 studies reached it within 17 months; a quarter within 6 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2026
First posted
Sep 4, 2026
StartActual
Oct 14, 2025
Primary completionEst.
Oct 8, 2026
CompletionEst.
Nov 30, 2026
Last update
Sep 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07805668
Lead sponsor
IRCCS Fondazione Stella Maris
Collaborators
Gaslini Children's Hospital
Responsible party
Sponsor
First posted
Sep 4, 2026
Start date
Oct 14, 2025
Primary completion
Oct 8, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Sep 4, 2026

Study contacts

valentina viglione
Contact
valentina.viglione@fsm.unipi.it
39050886293

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion